A combination product of lixisenatide with insulin glargine (Lantus) is available as SOLIQUA [soh LEE kwa]
Patients who already have reflux, constipation, irritable bowel symptoms, gallbladder history, diabetes medications, kidney concerns, low blood pressure, limited appetite, or difficulty maintaining protein intake should be especially proactive
Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA
Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study
(B,F) Dermal density (%) measured by DUB SkinScanner (green areas indicate higher density)
Missing doses during titration slows the entire process and may require restarting at a lower dose